Published
Novo Nordisk is the first drugmaker to introduce a highly effective weight-loss drug, Wegovy, at a time of record obesity rates.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.
#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.
#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance
- Category
- World
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:01
Novo Nordisk owner sees IPO window opening
-
01:26
Novo Nordisk became Europe's most valuable company
-
1:12:40
LIVE: Reuters NEXT Newsmaker featuring Sergio Ermotti, CEO of UBS
-
47:35
LIVE: Reuters NEXT Newsmaker featuring Japan Chief Cabinet Secretary Yoshimasa Hayashi | REUTERS
-
48:38
LIVE: Reuters Newsmaker with AstraZeneca CEO Pascal Soriot
-
Business Live: Novo Nordisk raises its forecasts fuelled by high demand for weight loss drugs
-
01:33
Novo Nordisk: Wegovy heart benefits due to more than weight loss
-
01:03
Novo Nordisk extends curbs on hot weight-loss drug
-
1:03:17
LIVE: Reuters Newsmaker with IAC Chairman Barry Diller
-
19:20
How Ozempic Accidentally Made Novo Nordisk A $400B Company
-
50:47
LIVE: Reuters Newsmaker with FDA Commissioner Robert Califf
-
01:22
Obesity drug maker Novo Nordisk lifts outlook again | REUTERS
-
01:03
Novo Nordisk says Wegovy wins China approval | REUTERS
-
04:30
LIVE: Reuters NEXT Newsmaker with EQT Chief Executive Christian Sinding
-
10:47
Biden assails Trump in fiery State of the Union speech and Ozempic maker Novo Nordisk's new pill
-
49:09
LIVE: Reuters Newsmaker with Emma Walmsley, CEO of GlaxoSmithKline
-
01:22
Novo Nordisk launches Wegovy in Britain
-
01:46
Novo Nordisk braces for Ozempic rivals in China | REUTERS
-
1:01:02
LIVE: Reuters Newsmaker with AustralianSuper CEO Paul Schroder
-
00:46
Wegovy maker Novo Nordisk says drug cuts risk of stroke by 20% – study
-
05:17
Sectors Upclose: Novo Nordisk is ‘almost like the Nvidia of Europe’
-
51:00
LIVE: Reuters Newsmaker with Benedetto Vigna, CEO of Ferrari
Loading...